Tissue Regenix's market cap is currently £31.70M. The company's EPS TTM is p-0.012; its P/E ratio is ―; Tissue Regenix is scheduled to report earnings on June 5, 2025, and the estimated EPS forecast is p0.00. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 29.49M	$ 19.87M	$ 14.36M	$ 12.83M	$ 13.03M
Gross Profit	$ 14.04M	$ 9.14M	$ 5.63M	$ 5.13M	$ 4.97M
Operating Income	$ -394.00K	$ -1.61M	$ -2.98M	$ -4.12M	$ -7.18M
EBITDA	$ 446.00K	$ -690.87K	$ -2.19M	$ -9.03M	$ -6.13M
Net Income	$ -1.71M	$ -2.19M	$ -3.48M	$ -9.71M	$ -6.97M
Balance Sheet
Cash & Short-Term Investments	$ 4.65M	$ 4.95M	$ 5.69M	$ 9.55M	$ 2.38M
Total Assets	$ 43.24M	$ 38.27M	$ 34.13M	$ 36.73M	$ 30.50M
Total Debt	$ 9.39M	$ 7.99M	$ 5.87M	$ 5.32M	$ 2.29M
Net Debt	$ 4.75M	$ 3.04M	$ 175.72K	$ -4.23M	$ -94.00K
Total Liabilities	$ 13.89M	$ 13.00M	$ 9.47M	$ 8.88M	$ 5.90M
Stockholders' Equity	$ 30.15M	$ 25.98M	$ 25.35M	$ 28.46M	$ 25.21M
Cash Flow
Free Cash Flow	$ 177.00K	$ -2.29M	$ -3.93M	$ -6.84M	$ -7.70M
Operating Cash Flow	$ 1.04M	$ -1.41M	$ -2.45M	$ -5.47M	$ -7.05M
Investing Cash Flow	$ -837.00K	$ -884.90K	$ -1.49M	$ -1.37M	$ -651.00K
Financing Cash Flow	$ -1.51M	$ 1.10M	$ 144.69K	$ 14.02M	$ 2.29M

Currency in USD

Tissue Regenix Earnings and Revenue History

Income Statement >

Tissue Regenix Debt to Assets

Balance Sheet >

Tissue Regenix Cash Flow

Cash Flow >

Tissue Regenix Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing